Skip to main content
Equibles

GOLDMAN SACHS GROUP INC

Position in REGN — Regeneron Pharmaceuticals, Inc.

CIK 886982 NEW YORK, NY
Back to REGN Full portfolio

Position in REGN

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$725,296,113
-$279,567,016 QoQ
Shares Held
1,163,191
-10.6% QoQ
Ownership
1.13%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 95% Shared 0% None 5%

Common Shares in REGN Over Time

Shares Held

Position Value (USD)

Derivatives in REGN

reported options exposure · as of Jun 30, 2026
CallValue
$106,687,694
CallShares
171,100
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

GOLDMAN SACHS GROUP INC holds $13,181,246,746 across 360 Biotechnology names. REGN ranks #2 (5.5% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 2,481,761 $1,232,765,138
2 REGN
Regeneron Pharmaceuticals, Inc.
This page 		1,163,191 $725,296,113
3 ROIV
Roivant Sciences Ltd.
 18,556,458 $656,713,046
4 TECH
BIO-TECHNE Corp
 7,343,324 $518,805,838
5 RVMD
Revolution Medicines, Inc.
 2,133,101 $399,487,154
6 MRNA
Moderna, Inc.
 4,671,950 $327,176,656
7 TNGX
Tango Therapeutics, Inc.
 9,980,620 $311,994,180
8 INCY
Incyte Corp
 2,305,782 $261,383,446

All Filings in REGN

Export CSV
50 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $106,687,694 171,100
2026-06-30 $725,296,113 1,163,191
2026-03-31 $12,748,560 16,500
2026-03-31 $144,947,264 187,600
2026-03-31 $1,004,863,129 1,300,558
2025-12-31 $26,320,767 34,100
2025-12-31 $151,440,894 196,200
2025-12-31 $846,993,788 1,097,327
2025-09-30 $535,752,781 952,839
2025-09-30 $14,112,977 25,100
2025-09-30 $147,989,464 263,200
2025-06-30 $14,227,500 27,100
2025-06-30 $418,008,150 796,206
2025-06-30 $141,435,000 269,400
2025-03-31 $15,475,212 24,400
2025-03-31 $530,909,490 837,093
2025-03-31 $178,599,168 281,600
2024-12-31 $256,723,732 360,400
2024-12-31 $459,194,270 644,637
2024-12-31 $25,643,880 36,000
2024-09-30 $640,250,360 609,043
2024-09-30 $68,330,600 65,000
2024-09-30 $303,177,616 288,400
2024-06-30 $53,707,633 51,100
2024-06-30 $723,717,183 688,579
2024-06-30 $270,640,225 257,500
2024-03-31 $39,462,090 41,000
2024-03-31 $366,632,650 380,921
2024-03-31 $50,145,729 52,100
2023-12-31 $20,112,841 22,900
2023-12-31 $37,678,641 42,900
2023-12-31 $326,535,045 371,785
2023-09-30 $323,563,180 393,170
2023-09-30 $20,327,112 24,700
2023-09-30 $21,890,736 26,600
2023-06-30 $29,963,118 41,700
2023-06-30 $27,376,374 38,100
2023-06-30 $360,728,634 502,030
2023-03-31 $358,065,706 435,778
2023-03-31 $49,300,200 60,000
2023-03-31 $48,232,029 58,700
2022-12-31 $405,986,028 562,705
2022-12-31 $72,726,192 100,800
2022-12-31 $26,406,534 36,600
2022-09-30 $297,533,283 431,915
2022-09-30 $5,235,412 7,600
2022-09-30 $7,577,570 11,000
2022-06-30 $2,009,842 3,400
2022-06-30 $245,392,840 415,125
2022-06-30 $4,019,684 6,800